Six years ago, genetic testing company 23andMe was a Silicon Valley success story, valued at an impressive $6 billion. Today, its CEO and co-founder, Anne Wojcicki, is attempting to buy back the struggling company for just $75 million. This dramatic fall in…
In a stunning turn of events, genetic testing giant 23andMe saw its entire board of directors resign on the same day, creating shockwaves throughout the biotech industry. The mass exodus has raised questions about the company’s future, but founder and CEO Anne…
